Bryan Jennings is an accomplished financial executive with extensive experience in the biotechnology and technology sectors. Currently serving as Chief Financial Officer at Partex since September 2025, Jennings is focused on leveraging big data and artificial intelligence to enhance drug discovery and development. Previous roles include Chief Financial Officer at BrightLake.ai, where efforts centered on AI-driven advertising technologies, and at LifeSci Advisors, LLC, providing financial leadership for various medical and biotech companies including BioPorto and Corvivo. Jennings also held the CFO position at TME Pharma, specializing in oncology treatments, and contributed as CFO at OrbiMed Advisors and Thiel Capital for biotech portfolio companies. A veteran of Morgan Stanley as Head of Capital Markets and Goldman Sachs as an Analyst, Jennings holds a Bachelor’s Degree in Political Science & Economics from Williams College and an M.B.A. in Finance and Accounting from Northwestern University's Kellogg School of Management.
This person is not in any teams
This person is not in any offices